Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › San Antonio › NPI 1598744856
Clinic

VHS San Antonio Partners LLC

VHS San Antonio Partners LLC was paid $36.89M by Medicaid between Jan 2019 and Dec 2024, across 157 billing codes. Its largest line is 99284, emergency room visit (serious) — 37% of everything it billed.

33Billing provider infoVHS SAN ANTONIO PARTNERS LLC
SAN ANTONIO, TX 78205
33aNPI1598744856assigned 01/13/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$36.89M
24GClaims426,707
24DCodes billed157
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers

Next to other Ambulatory Surgical Clinic/Center providers in Texas

Rank by total paid#13 of 320
Median peer was paid$205K
This provider vs. median180×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019754$16K
202015,665$1.63M
2021115,469$10.69M
2022134,087$13.44M
2023110,723$8.43M
2024incomplete50,009$2.69M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 37% 33,832 31,989 $13.60M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 20% 48,162 46,169 $7.54M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 19% 18,090 16,694 $7.17M
80053 Comprehensive metabolic panel 4.6% 46,614 42,714 $1.70M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.9% 47,214 42,774 $717K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.9% 4,532 4,313 $714K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1.9% 2,321 2,209 $683K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.9% 17,644 16,098 $683K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.2% 1,346 1,259 $456K
71045 Radiologic examination, chest; single view 1.1% 13,996 13,043 $418K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 90 89 $297K
81001 <1% 21,689 20,310 $253K
145 more codes
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 1,295 $221K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 267 $196K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 14,258 $158K
70450 Computed tomography, head or brain; without contrast material <1% 2,439 $132K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,746 $104K
96361 Intravenous infusion, hydration; each additional hour <1% 4,699 $99K
84484 <1% 8,050 $98K
84703 <1% 4,162 $90K
83690 <1% 5,649 $90K
87088 <1% 7,572 $84K
59025 Fetal non-stress test <1% 1,201 $83K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,215 $82K
96375 Therapeutic injection; each additional sequential IV push <1% 6,057 $82K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 839 $76K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 15 $69K
76801 <1% 704 $65K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 4,820 $58K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,948 $57K
71046 Radiologic examination, chest; 2 views <1% 1,513 $54K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 3,966 $52K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,327 $51K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,960 $50K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 4,218 $46K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,636 $38K
64643 <1% 165 $31K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,355 $30K
72125 Computed tomography, cervical spine; without contrast material <1% 846 $27K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,079 $24K
G0378 Hospital observation service, per hour <1% 252 $23K
86850 <1% 1,868 $22K
J7030 Infusion, normal saline solution , 1000 cc <1% 3,270 $20K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 752 $19K
87081 <1% 1,654 $19K
84702 <1% 1,555 $19K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,322 $16K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 75 $16K
83880 <1% 1,302 $15K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,437 $14K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 51 $12K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 525 $11K
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 1,697 $10K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,454 $9K
99223 Prolong inpt eval add15 m <1% 78 $9K
99218 <1% 36 $8K
80048 Basic metabolic panel (calcium, ionized) <1% 2,416 $7K
64642 <1% 96 $7K
74018 <1% 200 $7K
86140 <1% 470 $7K
85027 <1% 1,831 $6K
81025 <1% 727 $6K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 359 $5K
30930 <1% 13 $5K
99001 <1% 656 $5K
88300 <1% 140 $5K
87807 <1% 439 $5K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 205 $5K
83605 <1% 1,111 $5K
87040 <1% 791 $4K
86901 <1% 2,136 $4K
86900 <1% 2,088 $4K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 82 $4K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,948 $3K
87086 Culture, bacterial; quantitative colony count, urine <1% 301 $3K
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 1,357 $3K
87186 <1% 1,128 $3K
92567 <1% 116 $3K
81003 <1% 1,551 $3K
86762 <1% 202 $3K
96376 <1% 424 $3K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 284 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 557 $3K
86780 <1% 172 $2K
97162 <1% 218 $2K
83735 <1% 1,461 $2K
0002A <1% 260 $2K
85730 <1% 2,249 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 54 $2K
85610 <1% 2,524 $2K
86364 <1% 74 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 664 $2K
87077 <1% 702 $2K
85651 <1% 175 $2K
87467 <1% 132 $2K
84145 <1% 223 $2K
86258 <1% 60 $2K
84443 Thyroid stimulating hormone (TSH) <1% 310 $2K
71275 Computed tomographic angiography, chest, with contrast material <1% 14 $1K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 14 $1K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 968 $1K
0001A <1% 270 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,795 $1K
84112 <1% 45 $1K
92579 <1% 13 $1K
J7050 Infusion, normal saline solution, 250 cc <1% 720 $998.70
86231 <1% 59 $996.91
82784 <1% 72 $951.90
84439 <1% 70 $906.56
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,776 $866.04
L8613 Ossicula implant <1% 152 $767.37
92587 <1% 14 $732.68
92555 <1% 31 $659.90
87340 <1% 71 $634.73
0064U <1% 65 $582.30
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 713 $418.05
83036 Hemoglobin; glycosylated (A1C) <1% 248 $389.79
J1170 Injection, hydromorphone, up to 4 mg <1% 781 $355.57
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 39 $251.09
73030 <1% 14 $237.29
97163 <1% 30 $185.14
0031A <1% 28 $171.55
J1644 Injection, heparin sodium, per 1000 units <1% 574 $156.85
C1769 Guide wire <1% 82 $151.78
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,817 $147.60
J2704 Injection, propofol, 10 mg <1% 1,850 $141.04
82962 <1% 4,347 $140.90
82550 <1% 65 $128.08
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 214 $127.23
J0690 Injection, cefazolin sodium, 500 mg <1% 666 $117.26
84100 <1% 106 $115.73
80061 Lipid panel <1% 93 $114.22
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 181 $112.17
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 315 $109.51
J0360 Injection, hydralazine hcl, up to 20 mg <1% 106 $108.45
J2060 Injection, lorazepam, 2 mg <1% 224 $106.98
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 14 $77.89
85652 <1% 14 $67.51
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,251 $60.91
87641 <1% 15 $55.78
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 28 $51.31
87205 <1% 48 $46.57
90715 <1% 14 $40.43
80069 <1% 17 $35.42
87070 <1% 13 $29.88
94760 <1% 52 $21.68
A9270 Non-covered item or service <1% 3,360 $20.40
84379 <1% 25 $19.38
36415 Collection of venous blood by venipuncture <1% 1,222 $18.76
S0028 Injection, famotidine, 20 mg <1% 13 $15.24
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 27 $14.62
88342 0% 12 $0.00
J0687 Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg 0% 35 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 57 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 12 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 57 $0.00
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialREYES, ROGER (CFO)